Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spinal and Bulbar Muscular Atrophy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00972023
What this trial is testing

DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 1
Not applicableLooking for participantsNCT05647564
What this trial is testing

PET/CT Characterization of Treatment Resistance

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 25
Early research (Phase 1)Looking for participantsNCT07570979
What this trial is testing

Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 208
Testing effectiveness (Phase 2)Study completedNCT05694819
What this trial is testing

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

Who this might be right for
Salivary Gland Cancer
National Cancer Center Hospital East 57
Testing effectiveness (Phase 2)Study completedNCT06411912
What this trial is testing

NIDO-361 in Patients With SBMA

Who this might be right for
Spinal and Bulbar Muscular AtrophyKennedy's Disease
Nido Biosciences, Inc. 54
Large-scale testing (Phase 3)Looking for participantsNCT06592924
What this trial is testing

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Canadian Cancer Trials Group 830
Large-scale testing (Phase 3)Study completedNCT02294461
What this trial is testing

An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants

Who this might be right for
Progressive Metastatic Prostate Cancer
Astellas Pharma Inc 395
Testing effectiveness (Phase 2)Ended earlyNCT04754425
What this trial is testing

Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaCastration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted AgentsMetastatic Malignant Neoplasm in the Bone+5 more
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT07223385
What this trial is testing

High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

Who this might be right for
Prostate Cancer (Diagnosis)Prostate Cancer Stage IVCV Risk
Cedars-Sinai Medical Center 80
Testing effectiveness (Phase 2)WithdrawnNCT01612910
What this trial is testing

Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery

Who this might be right for
Breast Cancer Female
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT04335682
What this trial is testing

Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide

Who this might be right for
Metastatic Prostate CancerProstate Cancer MetastaticProstate Cancer+3 more
Alliance Foundation Trials, LLC. 111
Early research (Phase 1)Study completedNCT02411786
What this trial is testing

A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 40
Early research (Phase 1)Study completedNCT03264651
What this trial is testing

Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density

Who this might be right for
Mammographic Density
Havah Therapeutics Pty Ltd 9
Testing effectiveness (Phase 2)Ended earlyNCT03600467
What this trial is testing

Activity of Seviteronel in Patients With Androgen Receptor (AR)-Positive Glioblastoma

Who this might be right for
Solid TumorAndrogen Receptor Gene Overexpression
St Vincent's Hospital, Sydney 4
Not applicableStudy completedNCT03560661
What this trial is testing

Acoustic and Perceptual Markers of Dysarthria in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisKennedy's Disease
Assistance Publique - Hôpitaux de Paris 71
Large-scale testing (Phase 3)Study completedNCT00539305
What this trial is testing

Hormone and Information Processing Study

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
University of Washington 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03090165
What this trial is testing

Ribociclib and Bicalutamide in AR+ TNBC

Who this might be right for
Triple Negative Breast Cancer
Kari Wisinski 37
Testing effectiveness (Phase 2)Looking for participantsNCT06378866
What this trial is testing

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Who this might be right for
Recurrent Castration-Sensitive Prostate CarcinomaRecurrent Prostate CancerCastration-resistant Prostate Cancer+1 more
Mayo Clinic 532
Post-approval studies (Phase 4)Not Yet RecruitingNCT06195163
What this trial is testing

TRAP Study: Testosterone for Androgen Receptor Polymorphism

Who this might be right for
Fertility Disorders
Instituto Bernabeu 100
Early research (Phase 1)Ended earlyNCT05673109
What this trial is testing

AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc 8
Next Page